Premier Inc. sits between hospitals and suppliers. The question is whether its position creates durable owner returns or invites permanent scrutiny.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Premier (PINC) has seen its stock edge slightly higher this week, sparking some renewed attention from investors considering its ongoing performance. The move comes amid generally steady trading activity and invites a closer look at the company’s recent trends and fundamentals. See our latest analysis for Premier. Premier’s 32.2% year-to-date share price return stands out in what has otherwise been a gradual climb, with momentum picking up over the last quarter. However, when factoring in...

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Premier (PINC) posted a net profit margin of just 0.7% over the last twelve months, dramatically down from 11.2% a year ago, primarily due to a one-off loss of $162.9 million. While the company has achieved profitability in recent years, it has faced a 25.5% annual decline in earnings over the past five years. Still, with EPS forecast to surge 32.6% annually going forward, easily outpacing the broader US market even as revenue is set to rise just 1.5% per year, investors are eyeing both the...

Although the revenue and EPS for Premier (PINC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Premier (PINC) delivered earnings and revenue surprises of +7.14% and +0.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Healthcare tech company Premier (NASDAQ:PINC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 3.3% year on year to $240 million. Its non-GAAP profit of $0.32 per share was 17.5% above analysts’ consensus estimates.

Healthcare tech company Premier (NASDAQ:PINC) will be announcing earnings results this Tuesday before the bell. Here’s what investors should know.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 9.8% gain for healthcare stocks has fallen short of the S&P 500’s 22.6% rise.